PHA-10014 - MPharm Programme Stage 1
Coordinator: David Mottershead Room: HORBM2.32 Tel: +44 1782 7 34764
Lecture Time: See Timetable...
Level: Level 4
Credits: 120
Study Hours: 1200
School Office:

Programme/Approved Electives for 2020/21

None

Available as a Free Standing Elective

No

Co-requisites

None

Prerequisites





Barred Combinations

None

Description for 2020/21

The Stage 1 programme provides a truly integrated and fully contextualised introduction to the Keele MPharm degree. The programme is based upon a single 120-credit module that comprises three cycles of learning, assessment and reflection, and all topics progress logically and coherently with patient-oriented themes. The principal aim is to develop knowledge and skills in a wide variety of disciplines by demonstrating the linkages between seemingly disparate topics in science and practice that underpin all subsequent learning.
Rather than packaging material into small, discrete modules, the Stage 1 programme allows students to develop a deeper understanding of the topics covered: for example, examination of the structure and function of DNA and mRNA is preceded by studies in the basic chemistry which governs chemical bonding and molecular structure, and is followed by analyses of genetics and patient care. Studies in metabolism are underpinned by the principles of structure and bonding, and are delivered alongside topics in bioenergetics and reaction kinetics. Studies in pharmacy practice are supported throughout the programme by practical dispensing classes and developing topics in the essential and pharmaceutical sciences. In this way, the linkages between all strands of the programme are made clear and students equipped to study the later levels of the course.


Aims
The principal aim is to develop knowledge and skills in a wide variety of disciplines by demonstrating the linkages between seemingly disparate topics in science and practice that underpin all subsequent learning, and hence prepare the student for Stage 2 of the MPharm program.

Talis Aspire Reading List
Any reading lists will be provided by the start of the course.
http://lists.lib.keele.ac.uk/modules/pha-10014/lists

Intended Learning Outcomes

- Apply an integrated approach towards patient care which links pharmaceutical science and pharmacy practice
- Describe the concepts of health, illness, public health and the development of health policy, including the role of medicines in society
- Describe the structure and function of healthcare provision in the UK, including the regulation of healthcare professionals
- Recognise the key characteristics of a responsible and capable healthcare professional, including skills, attitudes and values
- Describe the roles of other healthcare professionals and the importance of interprofessional collaboration
- Demonstrate an understanding of the key features of the profession of pharmacy and the varied career profiles of pharmacists
- Describe and apply the underpinning legal framework for the sale and supply of medicines in the UK
- Demonstrate an ability to make sound and informed decisions in accordance with basic ethical principles
- Describe the basic architecture and cellular diversity of prokaryotic and eukaryotic cells
- Explain the essential aspects of metabolism at a cellular level

- Describe the different types of inter- and intracellular signalling systems in eukaryotic cells
- Describe the central role of thermodynamics, chemical kinetics and electrochemistry in biological systems
- Describe the cellular and molecular interactions involved in the formation and function of tissues
- Describe the role of genes in living organisms and how inheritance of genes affects human body systems
- Describe the normal anatomy and physiology of the major body systems
- Describe the structure and function of common receptor types
- Interpret pharmacological data to identify drug-target interactions
- Explain the common mechanisms by which drugs interact with physiological systems to exert pharmacological and adverse effects
- Interpret common pathological symptoms associated with abnormal functions in body systems
- Recognise and describe the structures and functions of molecules and their reactivity
- Describe how functional groups affect the physicochemical properties of molecules
- Describe how the physicochemical properties of molecules affect their formulation into medicines and the route of administration to patients
- Describe why a variety of dosage forms is necessary and the relative merits and demerits of the available forms
- Determine the purity and composition of compounds using appropriate practical and analytical techniques
- Describe the process of drug design and development from identification of target to formulation
- Describe and explain biopharmaceutics in terms of the relationship between dosage form and interaction of the drug substance with human physiology
- Demonstrate a high level of laboratory skill and apply a knowledge of the skills necessary for the successful completion of appropriate manipulative practical exercises
- Demonstrate competence in pharmaceutical calculations
- Communicate complex concepts effectively, both orally and in writing in a manner, that reflects professional practice
: 1,2,3,4,5,6,7

Study hours

Large- and small-group formal teaching sessions: 300 hours
Skills-based practical work and placements: 150 hours
Directed private study: 450 hours
Non-directed private study, revision and assessment: 300 hours



School Rules

None

Description of Module Assessment

1: Laboratory Assessment weighted 20%
Laboratory skills assessment
The laboratory assessment will comprise a laboratory report undertaken over the three cycles of Stage 1, including 1 formative and 1 summative prelab and proforma document.

2: Practical Assessment weighted 20%
Practical skills assessment
The assessment will comprise a variety of academic and professional skills-based tasks including essay(s), group work project(s) and presentation(s) undertaken over the three cycles of Stage 1 including formative opportunities.

3: Exam weighted 20%
Cycle 1 examinations
The end of cycle examination will comprise one paper in MCQ format. Formative tests will be provided prior to the examination to assist students with preparation. Low stakes summative assessments will be introduced to support student engagement with their studies. The low stakes assessments will be incorporated within this component and will comprise 15% of the overall mark. Examples may include MCQs, quizzes and other similar forms of assessment covering a variety of key topics from Cycle 1.

4: Exam weighted 20%
Cycle 2 examinations
The end of cycle examination will comprise one paper in MCQ format. Low stakes summative assessments will be introduced to support student engagement with their studies. The low stakes assessments will be incorporated within this component and will comprise 15% of the overall mark. Examples may include MCQs, quizzes and other similar forms of assessment covering a variety of key topics from Cycle 2.

5: Exam weighted 20%
Cycle 3 examinations
The end of cycle examination will comprise one paper in MCQ format. Low stakes summative assessments will be introduced to support student engagement with their studies. The low stakes assessments will be incorporated within this component and will comprise 15% of the overall mark. Examples may include MCQs, quizzes and other similar forms of assessment covering a variety of key topics from Cycle 3.

6: Professional Development weighted 0%
Professional skills development
The Professional Development assessment will include CPD activities, competency assessments (including calculations and communication skills), case studies in ethics, and evidence of professionalism measured by Professional Activity Credits.

7: Mixed Exam weighted 0%
End of year synoptic assessment
This assessment will comprise both group work and individual assessment. It will potentially cover all topics studied during the year, but will focus in particular on demonstrating understanding of the integration of those topics.